Results 151 to 160 of about 168,975 (262)

Through Parents' Eyes: Perspectives on Child Development and Family Experience During ESDM Intervention

Autism Research, EarlyView.
ABSTRACT Early intensive intervention for autistic children aims to support developmental progress in social and communication domains. Although outcomes are typically assessed using standardized measures of child development, parental perspectives during early intervention remain largely understudied.
Kenza Latrèche, Fiona Journal, Michel Godel, Martina Franchini, Nada Kojovic, David Cimasoni, Marcin Czajkowski, Lucie Delieutraz, Chloé Laubu, Marie Schaer   +9 more
wiley   +1 more source

Racial/Ethnic variation in health insurance coverage and early midlife depressive symptoms in the U.S. [PDF]

BMC Health Serv Res
Zhang X, Adams LB, Lemon TL.
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Health insurance coverage in Mexico: progress, inequalities and remaining challenges towards UHC2030. [PDF]

Health Res Policy Syst
Serván-Mori E, Cerecero-García D, Meneses-Navarro S, Hone T, Mohar-Betancourt A, Gómez-Dantés O.   +5 more
europepmc   +1 more source

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan

British Journal of Clinical Pharmacology, EarlyView.
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang, Chen‐Han Chueh, Chien‐Yu Tseng, Christopher N. Kaufmann, Earl J. Morris, Chiao‐En Wu, Yi‐Wen Tsai   +6 more
wiley   +1 more source

Insurance Coverage and Plan Choice Complexity for Medicare Beneficiaries With Cardiovascular Disease. [PDF]

Am J Cardiol
Shanab BM, Bunn DA, Oseran AS, Wadhera RK, Phelan J, Orav EJ, Figueroa JF.   +6 more
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Utilization of Fertility Treatment in Japan During the First Year of Insurance Coverage: Analysis of Real-World Health Claims Data. [PDF]

Reprod Med Biol
Okawara M, Kuwazuru T, Masunaga M, Fujimoto K, Nagata M, Iwasa T, Fujino Y.   +6 more
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Changes in Prescription Patterns and Diagnostic Outcomes of Polysomnography After Insurance Coverage: A Multicenter Retrospective Study. [PDF]

J Rhinol
Park DY, Cho JH, Park CS, Koh TK, Koo SK, Kim SW, Kim SJ, Kim YM, Kim JW, Kim JY, Kim HJ, Doo JG, Moon JW, Park MJ, Park SW, Park SI, Park S, Bae MR, Seo MY, Ahn SH, Yang HC, Lee KH, Lee SH, Lee YH, Lee EJ, Jun YJ, Jeon YJ, Chung YS, Chung J, Cho KS, Cho SW, Jo YS, Chae HS, Choi IS, Choi JH, Han SC.   +35 more
europepmc   +1 more source